Direct reprogramming of hematopoietic cells into hematopoietic stem cells
Project/Area Number |
23659483
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Hematology
|
Research Institution | Chiba University |
Principal Investigator |
IWAMA Atsushi 千葉大学, 大学院・医学研究院, 教授 (70244126)
|
Project Period (FY) |
2011 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
Keywords | ダイレクトリプログラミング / 造血幹細胞 |
Research Abstract |
Direct reprogramming of somatic cells into hematopoietic stem cells is challenging and has not been yet achieved. In this study, I tried to reprogram an E2A-deficient pro-B cell line, which retain multipotent differentiation capacity, into hematopoietic stem cells. Various combinations of key transcription factors known to be essential for hematopoietic stem cells were transduced into E2A-deficient pro-B cells and cultured on stromal cells in a medium which supports hematopoietic stem cells. I observed generation of myeloid cells expanding in culture, but failed to obtain hematopoietic stem cells in this trial. To achieve the real reprogramming, more technical renovation is definitely needed.
|
Report
(3 results)
Research Products
(38 results)
-
[Journal Article] Role of SOX17 in hematopoietic development from human embryonic stem cells.2013
Author(s)
Nakajima-Takagi Y, Osawa M, Oshima M, Takagi H, Miyagi S, Endoh M, Endo TA, Takayama N, Eto K, Toyoda T, Koseki H, Nakauchi H, and Iwama A.
-
Journal Title
Blood
Volume: 121
Pages: 447-458
Related Report
Peer Reviewed
-
[Journal Article] RUNX1/AML1 mutant collaborates with BMI1 overexpression in the development of human and murine myelodysplastic syndromes.2013
Author(s)
Harada Y, Inoue D, Ding Y, Imagawa J, Doki N, Matsui H, Yahata T, Matsushita H, Ando K, Sashida G, Iwama A, Kitamura T, and Harada H.
-
Journal Title
Blood
Volume: 121
Pages: 3434-3446
Related Report
Peer Reviewed
-
-
-
-
[Journal Article] Ezh2 augments leukemogenecity by reinforcing differentiation blockage in acute myeloid leukemia.2012
Author(s)
Tanaka S, Miyagi S, Sashida G, Chiba T, Yuan J, Mochizuki-Kashio M, Suzuki Y, Sugano S, Nakaseko C, Yokote K, Koseki H, and Iwama A.
-
Journal Title
Blood
Volume: 120
Pages: 1107-1117
Related Report
Peer Reviewed
-
[Journal Article] Circulating soluble LR11/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias.2012
Author(s)
Sakai S, Nakaseko C, Takeuchi M, Ohwada C, Shimizu N, Tsukamoto S, Kawaguchi T, Jiang M, Sato Y, Ebinuma H, Yokote K, Iwama A, Fukamachi I, Schneider WJ, Saito Y, and Bujo H.
-
Journal Title
Clinica Chemica Acta
Volume: 413
Pages: 1542-1548
Related Report
Peer Reviewed
-
[Journal Article] TET2 is essential for survival and hematopoietic stem cellhomeostasis.2012
Author(s)
Shide K, Kameda T, Shimoda H, Yamaji T, Abe H, Kamiunten A, Sekine M, Hidaka T, Katayose K, Kubuki Y, Yamamoto S, Miike T, Iwakiri H, Hasuike S, Nagata K, Iwama A, Matsuda T, Kitanaka A and Shimoda K.
-
Journal Title
Leukemia
Volume: 26
Pages: 2216-2223
Related Report
Peer Reviewed
-
-
[Journal Article] Bmi1 confers resistance to oxidative stress on hematopoietic stem cells.2012
Author(s)
Nakamura S, Oshima M, Yuan J, Saraya A, Miyagi S, Konuma T, Yamazaki S, Osawa M, Nakauchi H, Koseki H, and Iwama A.
-
Journal Title
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-